These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1466437)

  • 41. Erythropoietin use in a pregnant Jehovah's witness with anemia and beta-thalassemia: a case report.
    Bennett M; Macri CJ; Bathgate SL
    J Reprod Med; 2005 Feb; 50(2):135-7. PubMed ID: 15755051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Jehovah's Witness orthopaedic trauma patient: an ethical challenge.
    Simmons FM
    Orthop Nurs; 1999; 18(5):28-34. PubMed ID: 11052050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative management of severe acute anemia in a Jehovah's Witness.
    de Araújo Azi LM; Lopes FM; Garcia LV
    Transfusion; 2014 Apr; 54(4):1153-7. PubMed ID: 24117834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency.
    Pérez-Ferrer A; Gredilla E; de Vicente J; Laporta Y
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):651-3. PubMed ID: 21924639
    [No Abstract]   [Full Text] [Related]  

  • 45. Successful treatment of acute promyelocytic leukemia in a pregnant Jehovah's Witness with all-trans retinoic acid, rhG-CSF, and erythropoietin.
    Lin CP; Huang MJ; Liu HJ; Chang IY; Tsai CH
    Am J Hematol; 1996 Mar; 51(3):251-2. PubMed ID: 8619417
    [No Abstract]   [Full Text] [Related]  

  • 46. Preoperative erythropoietin in Jehovah's Witnesses who require cardiac procedures.
    Gaudiani VA; Mason HD
    Ann Thorac Surg; 1991 May; 51(5):823-4. PubMed ID: 2025093
    [No Abstract]   [Full Text] [Related]  

  • 47. Severe acute anaemia in a Jehovah's Witness. Survival without blood transfusion.
    Howell PJ; Bamber PA
    Anaesthesia; 1987 Jan; 42(1):44-8. PubMed ID: 3548474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erythropoietin and anemia of gastrointestinal bleeding in a Jehovah's Witness.
    Pousada L; Fiorito J; Smyth C
    Ann Intern Med; 1990 Apr; 112(7):552. PubMed ID: 2316946
    [No Abstract]   [Full Text] [Related]  

  • 49. A protocol avoiding allogeneic transfusion in joint arthroplasties.
    Suh YS; Nho JH; Choi HS; Ha YC; Park JS; Koo KH
    Arch Orthop Trauma Surg; 2016 Sep; 136(9):1213-1226. PubMed ID: 27450193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large volume polymerized haemoglobin solution in a Jehovah's Witness following abruptio placentae.
    Cothren CC; Moore EE; Long JS; Haenel JB; Johnson JL; Ciesla DJ
    Transfus Med; 2004 Jun; 14(3):241-6. PubMed ID: 15180817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of a multiply injured Jehovah's Witness with severe acute anemia.
    Rupp RE; Ebraheim NA; Saddemi SR; Wido T
    Orthop Rev; 1993 Jul; 22(7):847-50. PubMed ID: 8414661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Erythropoietin made surgery for aortic coarctation possible in a Jehovah's witness patient].
    Haldén E; Birgegård G; Duvernoy O; Henze A
    Lakartidningen; 1991 Dec; 88(49):4245-6. PubMed ID: 1758229
    [No Abstract]   [Full Text] [Related]  

  • 54. "Bloodless" treatment of a Jehovah's Witness infant with ABO hemolytic disease.
    Lakatos L; Csáthy L; Nemes E
    J Perinatol; 1999; 19(7):530-2. PubMed ID: 10685306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of multiple myeloma associated anemia with human recombinant erythropoietin in a hemodialysis patient].
    Muszytowski M; Nowak J; Wojnicz M; Zalewska A; Ruszkiewicz-Fołda M
    Pol Arch Med Wewn; 1995 Jan; 93(1):77-9. PubMed ID: 7479222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
    Ovali F; Samanci N; Dağoğlu T
    Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of recombinant activated factor VII for reduction of perioperative blood loss during elective surgical correction of spine deformity in a Jehovah's Witness. Case report.
    Kącka K; Kącki W; Merak J; Błęka A
    Ortop Traumatol Rehabil; 2010; 12(5):448-58. PubMed ID: 21057153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythropoietin treatment of chronic anaemia of cancer.
    Ludwig H; Leitgeb C; Fritz E; Krainer M; Kührer I; Kornek G; Sagaster P; Weissmann A
    Eur J Cancer; 1993; 29A Suppl 2():S8-12. PubMed ID: 8398362
    [No Abstract]   [Full Text] [Related]  

  • 59. Erythropoietin for anemia in Jehovah's Witnesses.
    Green D; Handley E
    Ann Intern Med; 1990 Nov; 113(9):720-1. PubMed ID: 2221656
    [No Abstract]   [Full Text] [Related]  

  • 60. Very low doses of GM-CSF administered alone or with erythropoietin in aplastic anemia.
    Kurzrock R; Talpaz M; Gutterman JU
    Am J Med; 1992 Jul; 93(1):41-8. PubMed ID: 1626572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.